A new study reports that in 2010–2019, mortality owing to non-communicable diseases continued to decline in the majority of countries worldwide. However, the data also highlight major disparities between countries and a widespread slowing of progress in reducing mortality compared to the previous decade.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204–1222 (2020).
NCD Countdown 2030 Collaborators. Benchmarking progress in non-communicable diseases: a global analysis of cause-specific mortality from 2001 to 2019. Lancet 406, 1255–1282 (2025).
World Health Organization. Tackling NCDs: Best Buys and Other Recommended Interventions for the Prevention and Control of Noncommunicable Diseases 2nd edn (WHO, 2024).
Neufeld, M., Ferreira-Borges, C., Gil, A., Manthey, J. & Rehm, J. Alcohol policy has saved lives in the Russian Federation. Int. J. Drug Policy 80, 102636 (2020).
Simpson, S. J., Saint, V. & Bozorgmehr, K. Changing the discourse in ambitions towards universal health coverage: lessons from Australian primary healthcare; comment on “universal health coverage for non-communicable diseases and health equity: lessons from Australian primary healthcare”. Int. J. Health Policy Manag. 11, 851–854 (2022).
Joo, J. Y. Fragmented care and chronic illness patient outcomes: a systematic review. Nurs. Open 10, 3460–3473 (2023).
Coates, M. et al. Maintaining non-communicable disease (NCD) services during the COVID-19 pandemic: lessons from Thailand. BMJ Glob. Health 8 (Suppl. 6), e014695 (2024).
Hanna, T. P. et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ 371, m4087 (2020).
Iburg, K. M., Mikkelsen, L., Adair, T. & Lopez, A. D. Are cause of death data fit for purpose? Evidence from 20 countries at different levels of socio-economic development. PLoS ONE 15, e0237539 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author reports consulting fees and/or honoraria from Bayer, AstraZeneca, Boehringer Ingelheim, Baxter, Vera, Visterra, Otsuka, Novartis, Timberlyne, Biogen, Chinook and Alpine under the policy of all payments going to the George Institute.
Rights and permissions
About this article
Cite this article
Jha, V. Slowing of progress in reducing non-communicable disease mortality. Nat Rev Nephrol 22, 8–9 (2026). https://doi.org/10.1038/s41581-025-01033-1
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41581-025-01033-1
